Pharma Reviews: When Modi meets Trump, buying defence equipment shouldn't be on the agenda

The same policy is also a threat to India's $36 billion pharmaceutical industry, by way of delayed approvals for Indian drug makers. Before the meet ...
Read more: When Modi meets Trump, buying defence equipment shouldn't be on the agenda